<![CDATA[Astria Therapeutics, Inc. 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=47472>Wed, 13 May 2026 19:28:02 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Astria Therapeutics Initiates ALPHA-ORBIT Phase 3 Pivotal Trial of Navenibart in Hereditary Angioedema]]>https://www.newswire.co.kr/newsRead.php?no=1006692Mon, 03 Mar 2025 12:00:00 +0900<![CDATA[아스트리아 테라퓨틱스, 유전성 혈관부종 환자 대상 나베니바트의 알파-오빗 3상 중추적 임상시험 개시]]>https://www.newswire.co.kr/newsRead.php?no=1006693Mon, 03 Mar 2025 12:00:00 +0900